Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

ECT anesthetic doses under the microscope: no new treatment, just observation

NCT ID NCT07418463

Knowledge-focused Sponsor: Izmir City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watched 60 adults getting electroconvulsive therapy (ECT) for severe depression to see if their need for anesthesia changed over multiple sessions. Researchers measured the dose of anesthetic used each time and how it related to seizure quality and recovery. No new treatments were given—just routine care was observed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

Mar 2026

Finished

Jun 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients aged 18-65 years with an established indication for electroconvulsive therapy (ECT) who are scheduled to undergo multiple ECT sessions at a tertiary care hospital. Participants will be consecutively enrolled during the study period according to eligibility criteria. All procedures will be performed as part of routine clinical care.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 to 65 years. * Scheduled to undergo electroconvulsive therapy (ECT) under elective conditions as part of routine clinical care. * ECT indication (e.g., major depressive disorder, bipolar depression, schizoaffective disorder, catatonia). * ASA Physical Status I-III. * Planned to receive multiple ECT sessions. * Able to provide written informed consent (participant and/or legally authorized representative). Exclusion Criteria: * Use of antiepileptic drugs or benzodiazepines that may affect seizure threshold. * ECT received within the past 6 months. * Severe cardiovascular, pulmonary, or neurologic comorbidity (investigator judgment). * Pregnancy or breastfeeding. * ASA Physical Status IV or higher. * Acute substance or alcohol use disorder/intoxication. * Conditions preventing EEG monitoring (e.g., scalp trauma, significant skin lesions, cranial implants). * Inability to obtain reliable BIS monitoring during anesthesia induction due to technical limitations.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bipolar depression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bipolar depression catatonia major depressive disorder schizoaffective disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Electroconvulsive therapy

Contacts and locations

Locations

  • Izmir City Hospital

    Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.